Clinical Studies

Home / Clinical Studies

Immuno-Oncology Pipeline

As of January 2017

ALL = acute lymphoblastic leukemiaAML = acute myeloid leukemiaBiCAR = bispecific CAR
CLL = chronic lymphocytic leukemia DLBCL = diffuse large b-cell lymphoma HL = Hodgkin lymphoma
KO = knockoutNSCLC = lung adenocarcinoma
As at January 2017